Succinate-semialdehyde dehydrogenase, mitochondrial


  • Accession: P51649
  • Swissprot: SSDH_HUMAN
  • Organism: Homo sapiens
  • Gene: ALDH5A1
  • Target class: Enzyme

Drug Relations:

valproic acid
A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Bioactivity details MOA